EMYRA

What this means for you

Not registered yet, but its 01 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

99315665

Mark type

Stylized text

Filed

01 Aug 2025

Attorney of record

Lucas R. Yordy

Goods and services

• Class 042 — Scientific and technological services: Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genetic test results, predicting how patients will metabolize drugs, and tailoring patient treatment plans based on patient genetics to improve efficacy and minimize side effects; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for tailoring patient treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing genetic test results to optimize drug therapy; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for accessing and analyzing clinical guidelines, drug label annotations, and FDA drug label data to inform treatment plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing DNA test results to ensure optimal drug selection and dosing; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for integration with electronic health record systems of medical providers; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing gene-drug, drug-drug, food-drug interactions and nutrigenomics data to optimize drug therapy and nutrition plans; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing current and proposed patient treatment plans to identify known interactions between drugs that could lead to reduced effectiveness or adverse reactions; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing current and proposed patient treatment plans to identify dietary elements that may interfere with how medications are absorbed or metabolized; Artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for analyzing patient genetic test results related to nutrient metabolism and generating personalized dietary guidance to optimize health and support medication regimens

Owner

• Sherpa Rx, Inc., Nashville, TN, US

Prosecution history

• 18 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 18 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 18 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 18 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Dec 2025 — NON-FINAL ACTION E-MAILED
• 18 Dec 2025 — NON-FINAL ACTION WRITTEN
• 16 Dec 2025 — ASSIGNED TO EXAMINER
• 07 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 01 Aug 2025 — APPLICATION FILING RECEIPT MAILED
• 01 Aug 2025 — NEW APPLICATION ENTERED